Fundz

Aurealis Therapeutics Raises $10 Million Series A To Drive Multi-Factor Bacterial Vectors In Chronic Wounds And Oncology

PRIVATEMar 30, 2023

Amount Raised

$10 Million

Round Type

Series A

La JollaBiotechnologyHealth CareTherapeutics

Description

AUREALIS THERAPEUTICS RAISES $10 MILLION IN AN OVERSUBSCRIBED SERIES A FINANCING TO ACCELERATE PHASE 2 CLINICAL STUDIES IN CHRONIC WOUNDS AND PRECLINICAL DEVELOPMENT IN ONCOLOGY WITH ITS FIRST-IN-CLASS TECHNOLOGY PLATFORM

Quick answer

Arialys Therapeutics raised $10 Million in a Series A round, dated March 30, 2023. Arialys Therapeutics is based in La Jolla, California, United States.

How much did Arialys Therapeutics raise?
Arialys Therapeutics raised $10 Million in a Series A round on March 30, 2023.
What does Arialys Therapeutics do?
Arialys Therapeutics is developing new precision medicines to specifically block pathogenic autoantibodies in the brain, aiming to expand treatment possibilities for neuropsychiatric disorders driven by autoimmune..
Where is Arialys Therapeutics based and how big is it?
Arialys Therapeutics is based in La Jolla, California, United States.
Who are the decision-makers at Arialys Therapeutics?
Fundz holds 2 contacts at Arialys Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Arialys Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Decoy Therapeutics Inc. raised $6M on May 11, 2023.
  • ARTHEx Biotech raised $46M (Series B) on May 3, 2023.
  • Convergent Therapeutics raised $90M (Series A) on May 3, 2023.
  • Zura Bio raised $16M on May 1, 2023.
  • Convergent Therapeutics raised $29M on April 27, 2023.
  • HCW Biologics raised $26M (Debt Financing) on April 27, 2023.

Who to call at Arialys Therapeutics, and when

A new round usually means Arialys Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arialys Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arialys Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arialys Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arialys Therapeutics

Location

La Jolla, California, United States

About

Arialys Therapeutics is developing new precision medicines to specifically block pathogenic autoantibodies in the brain, aiming to expand treatment possibilities for neuropsychiatric disorders driven by autoimmune disease. Founded to explore the latest discoveries in autoimmune neuropsychiatry, the company is advancing a novel approach based on the growing understanding that immune cells—not only in the body’s periphery but especially in the brain—can produce autoantibodies that cause severe neurological and psychiatric conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arialys Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Arialys Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Arialys Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.